1,6-naphthyridinone derivatives having angiotension II antagonist activity
US5294620A · kind A · utility
61Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 1993 |
| Grant date | Mar 15, 1994 |
| Priority date | — |
| Expiry date | Apr 2, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns pharmaceutically useful compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, Ra, Rb, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.